Skip to main content
Top
Published in: Drugs & Aging 5/2014

01-05-2014 | Short Communication

Attitudes of Older Adults to Their Participation in Clinical Trials: A Pilot Study

Authors: Frédéric Bloch, Nathalie Charasz

Published in: Drugs & Aging | Issue 5/2014

Login to get access

Abstract

Background and objectives

Elderly subjects are still poorly represented in clinical trials, because of unjustified upper age limits. The prejudged reluctance of elderly patients to participate in trials could also be a barrier to their inclusion. The objective of this pilot study was to clarify the position of elderly subjects on their motivations and the reasons for their ultimate refusal to participate in clinical trials.

Method

A questionnaire survey was administered to 150 elderly subjects, aged 70 years or over, living at home, in long-term care units, or hospitalized.

Results

Only 44 % of the sample population answered that they would agree to participate in a trial that afforded personal benefit. These results did not depend on age but rather on health condition and sex. Motivations were mostly altruistic rather than based on personal concerns. The main reasons for refusal were fear that the experiment could damage their health and that they thought they were too old.

Conclusion

Elderly subjects are not inclined to participate in clinical trials. In the future, we should aim to increase the information on clinical trials for older patients and train researchers appropriately if we wish to increase the participation levels of this age group in such trials. More research is needed on a larger sample.
Literature
1.
go back to reference Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature. 2008;451(7179):716–9.PubMedCrossRef Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature. 2008;451(7179):716–9.PubMedCrossRef
2.
go back to reference Culberson JW, Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics. 2008;63(9):22–31.PubMed Culberson JW, Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics. 2008;63(9):22–31.PubMed
3.
go back to reference Merle L, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22(5):375–92.PubMedCrossRef Merle L, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22(5):375–92.PubMedCrossRef
5.
go back to reference Bloch F, Abitbol G, Haulon S, et al. Could, in the future, clinical trials include more elderly subjects? Rev Geriatr. 2001;26(10):783–4. Bloch F, Abitbol G, Haulon S, et al. Could, in the future, clinical trials include more elderly subjects? Rev Geriatr. 2001;26(10):783–4.
6.
go back to reference Schmucker DL, Vesell ES. Are the elderly under-represented in clinical drug trials? J Clin Pharmacol. 1999;11:1103–8. Schmucker DL, Vesell ES. Are the elderly under-represented in clinical drug trials? J Clin Pharmacol. 1999;11:1103–8.
7.
go back to reference Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ. 2000;321(7267):992–3.PubMedCentralPubMedCrossRef Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ. 2000;321(7267):992–3.PubMedCentralPubMedCrossRef
8.
go back to reference Cruz-Jentoft AJ, Gutiérrez B. Upper age limits in studies submitted to a research ethics committee. Aging Clin Exp Res. 2010;22(2):175–8.PubMedCrossRef Cruz-Jentoft AJ, Gutiérrez B. Upper age limits in studies submitted to a research ethics committee. Aging Clin Exp Res. 2010;22(2):175–8.PubMedCrossRef
9.
go back to reference Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc. 2010;58(9):1791–6.PubMedCrossRef Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc. 2010;58(9):1791–6.PubMedCrossRef
10.
go back to reference Hames A, Wynne HA. Unlicensed and off-label drug use in elderly people. Age Ageing. 2001;30(6):530–1.PubMedCrossRef Hames A, Wynne HA. Unlicensed and off-label drug use in elderly people. Age Ageing. 2001;30(6):530–1.PubMedCrossRef
11.
go back to reference Crome P, Lally F, Cherubini A, et al. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011;28(8):667–77.PubMedCrossRef Crome P, Lally F, Cherubini A, et al. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011;28(8):667–77.PubMedCrossRef
12.
go back to reference Herzog AR, Rogjers WL. Age and response rates to interview sample surveys. J Gerontol. 1988;6:S200–5.CrossRef Herzog AR, Rogjers WL. Age and response rates to interview sample surveys. J Gerontol. 1988;6:S200–5.CrossRef
13.
go back to reference Thomas P, Ingrand P, Lalloue F, et al. Reasons of informal caregivers for institutionalizing dementia patients previously living at home: the Pixel study. Int J Geriatr Psychiatry. 2004;19(2):127–35.PubMedCrossRef Thomas P, Ingrand P, Lalloue F, et al. Reasons of informal caregivers for institutionalizing dementia patients previously living at home: the Pixel study. Int J Geriatr Psychiatry. 2004;19(2):127–35.PubMedCrossRef
14.
go back to reference Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA. 2002;287(3):337–44.PubMedCrossRef Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA. 2002;287(3):337–44.PubMedCrossRef
15.
go back to reference Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist. 1990;1:100–6.CrossRef Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist. 1990;1:100–6.CrossRef
16.
go back to reference Arean PA, Gallagher-Thompson D. Issues and recommendations for the recruitment and retention of older ethnic minority adults into clinical research. J Consult Clin Psychol. 1996;5:875–80.CrossRef Arean PA, Gallagher-Thompson D. Issues and recommendations for the recruitment and retention of older ethnic minority adults into clinical research. J Consult Clin Psychol. 1996;5:875–80.CrossRef
17.
go back to reference Comis RL, Miller JD, Aldigé CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21(5):830–5.PubMedCrossRef Comis RL, Miller JD, Aldigé CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21(5):830–5.PubMedCrossRef
18.
go back to reference Kessenich CR, Guyatt GH, Rosen CJ. Health-related quality of life and participation in osteoporosis clinical trials. Calcif Tissue Int. 1998;3:189–92.CrossRef Kessenich CR, Guyatt GH, Rosen CJ. Health-related quality of life and participation in osteoporosis clinical trials. Calcif Tissue Int. 1998;3:189–92.CrossRef
19.
go back to reference Leader M, Neuwirth E. Clinical research and the non-institutional elderly: a model for subject recruitment. J. Am Geriatric Soc. 1978;26:27–31. Leader M, Neuwirth E. Clinical research and the non-institutional elderly: a model for subject recruitment. J. Am Geriatric Soc. 1978;26:27–31.
20.
go back to reference Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: do double standards still apply? J Womens Health Gend Based Med. 2001;10:757–64.PubMedCrossRef Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: do double standards still apply? J Womens Health Gend Based Med. 2001;10:757–64.PubMedCrossRef
21.
go back to reference Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86:1766–70.PubMedCrossRef Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst. 1994;86:1766–70.PubMedCrossRef
22.
go back to reference Nordin AJ, Chinn DJ, Moloney I, et al. Do elderly cancer patients care about cure? Attitudes to radical gynecologic oncology surgery in the elderly. Gynecol Oncol. 2001;81:447–55.PubMedCrossRef Nordin AJ, Chinn DJ, Moloney I, et al. Do elderly cancer patients care about cure? Attitudes to radical gynecologic oncology surgery in the elderly. Gynecol Oncol. 2001;81:447–55.PubMedCrossRef
23.
go back to reference Townsley CA, Chan KK, Pond GR, et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer. 2006;8(6):34.CrossRef Townsley CA, Chan KK, Pond GR, et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer. 2006;8(6):34.CrossRef
24.
go back to reference Diener L, Hugonot-Diener L, Alvino S, et al. Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations. J Nutr Health Aging. 2013;17(7):625–7.PubMedCrossRef Diener L, Hugonot-Diener L, Alvino S, et al. Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations. J Nutr Health Aging. 2013;17(7):625–7.PubMedCrossRef
25.
go back to reference Konrat C, Boutron I, Trinquart L, et al. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7(3):e33559. doi:10.1371/journal.pone.0033559. (Epub 2012 Mar 30). Konrat C, Boutron I, Trinquart L, et al. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7(3):e33559. doi:10.​1371/​journal.​pone.​0033559. (Epub 2012 Mar 30).
26.
go back to reference Aapro MS, Köhne CH, Cohen HJ, et al. Never too old? Age should not be a barrier to enrolment in cancer clinical trials. Oncologist. 2005;10(3):198–204.PubMedCrossRef Aapro MS, Köhne CH, Cohen HJ, et al. Never too old? Age should not be a barrier to enrolment in cancer clinical trials. Oncologist. 2005;10(3):198–204.PubMedCrossRef
Metadata
Title
Attitudes of Older Adults to Their Participation in Clinical Trials: A Pilot Study
Authors
Frédéric Bloch
Nathalie Charasz
Publication date
01-05-2014
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 5/2014
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-014-0168-2

Other articles of this Issue 5/2014

Drugs & Aging 5/2014 Go to the issue